1. Home
  2. PAHC

as of 12-18-2025 3:54pm EST

$40.78
+$0.18
+0.44%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

Chart Type:
Time Range:
Founded: 1946 Country:
United States
United States
Employees: N/A City: TEANECK
Market Cap: 1.6B IPO Year: 2014
Target Price: $31.25 AVG Volume (30 days): 273.3K
Analyst Decision: Hold Number of Analysts: 4
Dividend Yield:
1.18%
Dividend Payout Frequency: Quarterly
EPS: 1.67 EPS Growth: 288.74
52 Week Low/High: $16.16 - $46.42 Next Earning Date: 02-04-2026
Revenue: $1,399,676,000 Revenue Growth: 33.72%
Revenue Growth (this year): 15.34% Revenue Growth (next year): 3.28%

AI-Powered PAHC Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 75.38%
75.38%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Stock Insider Trading Activity of Phibro Animal Health Corporation (PAHC)

BENDHEIM JACK

President and CEO

Sell
PAHC Dec 11, 2025

Avg Cost/Share

$40.91

Shares

5,752

Total Value

$235,404.68

Owned After

42,195

BENDHEIM JACK

President and CEO

Sell
PAHC Dec 9, 2025

Avg Cost/Share

$40.19

Shares

1,288

Total Value

$51,763.30

Owned After

42,195

SEC Form 4

BENDHEIM JACK

President and CEO

Sell
PAHC Dec 8, 2025

Avg Cost/Share

$40.06

Shares

3,520

Total Value

$141,017.54

Owned After

42,195

SEC Form 4

BENDHEIM JACK

President and CEO

Sell
PAHC Dec 4, 2025

Avg Cost/Share

$41.46

Shares

3,520

Total Value

$145,095.90

Owned After

42,195

BENDHEIM JACK

President and CEO

Sell
PAHC Dec 3, 2025

Avg Cost/Share

$40.77

Shares

3,520

Total Value

$143,510.75

Owned After

42,195

SEC Form 4

BENDHEIM JACK

President and CEO

Sell
PAHC Dec 1, 2025

Avg Cost/Share

$41.66

Shares

3,520

Total Value

$146,636.16

Owned After

42,195

SEC Form 4

BENDHEIM JACK

President and CEO

Sell
PAHC Nov 28, 2025

Avg Cost/Share

$42.54

Shares

3,520

Total Value

$149,740.10

Owned After

42,195

SEC Form 4

BENDHEIM JACK

President and CEO

Sell
PAHC Nov 26, 2025

Avg Cost/Share

$44.02

Shares

5,280

Total Value

$232,434.05

Owned After

42,195

SEC Form 4

BENDHEIM JACK

President and CEO

Sell
PAHC Nov 25, 2025

Avg Cost/Share

$43.93

Shares

7,040

Total Value

$309,239.74

Owned After

42,195

SEC Form 4

BENDHEIM JACK

President and CEO

Sell
PAHC Nov 20, 2025

Avg Cost/Share

$42.04

Shares

3,520

Total Value

$147,001.69

Owned After

42,195

Share on Social Networks: